Private Equity

Puxin Capital

Investment Details

Investor Type
Private Equity

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Early Stage, Growth, Buyout

Geographical Focus
United States, China

Industries Focus

  • Financial Services
  • Technology
  • Materials
  • Information Services
  • Retail
  • Software
  • Business Services
  • Transportation
  • Construction
  • Manufacturing
  • Entertainment
  • Biotechnology
  • Mining
  • Electronics
  • Food

Investor Details Founded: 2014

Puxin Capital is a private equity firm headquartered in Beijing, China, specializing in early-stage and growth investments across a diverse range of industries. The firm strategically targets opportunities in biotechnology, business services, construction, electronics, entertainment, financial services, food, information services, manufacturing, materials, mining, retail, software, technology, and transportation.

The firm's investment approach encompasses venture, growth, and buyout opportunities, allocating capital across a diversified spectrum of industries. Puxin Capital has demonstrated a strong acquisition and integration expertise, effectively improving education quality and operational performance of acquired companies. This approach has differentiated the firm from other after-school education service providers in China.

Puxin Capital has a track record of active investments, with notable recent deals including a Series A investment in Giga AI on December 8, 2025, and a Series B investment in JBD on October 27, 2025. The firm's portfolio reflects its commitment to fostering growth and innovation across various sectors, contributing to the development of China's dynamic economy.

Requirements
  • Strong acquisition and integration capabilities
  • Focus on improving operational performance
  • Diversified industry interests
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Giga AI
  • JBD
  • PaXini Tech
  • AlpsenTek
  • Anda Biopharma
  • AI-LINK
  • Sinogen Biopharma
  • Spacetouch
  • Hua Kong TsingJiao
  • Ab&B Biotech
  • XunceTech
Claim this Investor

Are you an official representative of Puxin Capital?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim